Upcoming Webinars

Aggregation Analysis in AAV: Selecting Fit-for-Purpose Assays

Presented by Margaret Butko, Ph.D., Senior Advisor of CMC Assay Development at Eli Lilly and Company, Rickard Nordström Chief Operating Officer at QuTEM
02nd December 2026


Integrating E&L Assessment and Filter Validation for Sterilizing Grade Filters used in (Bio-)Pharmaceutical Manufacturing

Presented by Presented by Lijun Song, PhD, Scientific Project Manager at Nelson Labs and Peter Cornelis, Senior expert Microbiology and Sterilization at Nelson Labs
10th December 2026


Applied Automation and Mechanistic Modeling for Purification Development of Challenging Molecules under Accelerated Timelines

Presented by Scott H. Altern, Senior Scientist II at AbbVie Bioresearch Center in Worcester, MA, Pia Graf, Senior Global Product Manager, Fast Trak™ Downstream Process Development at Cytiva.
11th January 2027


Navigating Assay Re-Development & Transfer to Reduce Risk & Delays in GMP Testing

Presented by Sviatlana Rose, Principal Scientist at Sanofi
15th January 2027


Strategies for Successful Implementation of New Technologies in Biomanufacturing

Presented by Irina Ramos, PhD, Senior Distinguished Scientist, CMC and Innovation Lead at J&J Innovative Medicine
19th January 2027


Controlling Cryoinjury in Cell Therapy: From Freezing, Formulation Design to Clinical Readiness

Presented by Nirnoy Dan, PhD. Senior Scientist at AstraZeneca
21st January 2027


PAT Evolution and Implementation: Navigating Regulatory Guidelines, and Best Practices for Tool Selection and Validation

Presented by Presented by Dr. Farshid Mohammadparast, Process Analytical Technology (PAT) and Chemometrics Principal Investigator at USP, Atanu Sengupta, Lead – New Technologies & External Collaborations at Dr. Reddy’s Laboratories, Parag Borgaonkar, MBA, Sr. Business Development Specialist at Thermo Fisher Scientific, Sudhir Dahal, PhD., Product Marketing Manager for Research Raman Products at Thermo Fisher Scientific
25th January 2027


Scaling Up TFF for Upstream Continuous Processing: Applications of Mechanistic Modeling

Presented by Ashna Dhingra, Bioprocess Technologies & Engineering, Senior Scientist, AstraZeneca, April Wheeler, Senior Product Manager, Microfiltration Technologies at Asahi Kasei Bioprocess
28th January 2027


Process Development to GMP Implementation of Raman Spectroscopy as a PAT Tool for the Purification of Protein Based Therapeutics

Presented by Christina Passno, Senior Staff Engineer, Preclinical Manufacturing & Process Development at Regeneron Pharmaceuticals, Nimesh Khadka, Ph.D. Senior Products Specialist at Thermo Fisher Scientific
02nd February 2027


Accelerating Biologics Development Through Advanced Analytics and Digital Transformation

Presented by Christian Airiau, PhD, Global Head Data Sciences, CMC at Sanofi, Patrick Ansems, Global Head of Life Sciences at Siemens Digital Industries Software
03rd February 2027


Supporting Quality across the mRNA Product Lifecycle: From Raw Materials to CQA Assessment

Presented by Sarita Kattel, M.S, Principal Scientist, Global Biologics at US Pharmacopeia
04th February 2027


The Path to Laboratory Transformation: From Scientific Work to Scalable Capability

Presented by Leonard Blackwell, Ph.D. Senior Consultant, Lab of the Future & Robotics at Hyperplane LLC Saly Romero-Torres, Ph.D. Owner, Hyperplane LLC, Followed by Dr. Cenk Ündey, PhD, Global iCMC Digital Transformation Program Business Lead at Sanofi
11th February 2027


Fit for Purpose Chemical Characterization Studies for Medical Devices: A Practical Approach

Presented by Sandi Schaible, President and Founder of Bonded in Science, LLC
24th February 2027


A Systematic Approach to Responding to Microbial Contamination Events in Biopharmaceutical Manufacturing

Presented by Hilary Chan, Global Sterility Assurance and Microbiology Lead at Takeda, Doug Botkin, PhD, Scientific Portfolio Specialist at Charles River Laboratories
03rd March 2027


Transforming Biomanufacturing: Why Architecture Must Precede Analytics

Presented by Martin Kockx, Principal Business Analyst & Architect in AI Systems, CMC Technology at Vertex Pharmaceuticals
16th March 2027


Confirming Gene Modifications on Release Using Flow Cytometry Assays

Presented by Akshata Ijantkar, Sr Principal Scientist at Bristol Myers Squibb.
13th April 2027


Roundtable Discussion: Bridging Across Analytical Methods for Therapeutic Proteins and Novel Modalities

Presented by Dr. Anthony Blaszczyk, Principal Scientist in the Global Biologics Department at U.S. Pharmacopeia, Lili Belcastro, PhD. Associate Director, Raw Materials, Drug Product Process Development at Bristol Myers Squibb
26th April 2027